NYMC Faculty Publications
Frequency of Infusion-Related Reactions with CPX-351 Treatment in an Observational Study in Adults with Newly Diagnosed Therapy-Related AML or AML with Myelodysplasia-Related Changes (AML-MRC)
Author Type(s)
Faculty
DOI
10.1080/10428194.2021.1919668
Journal Title
Leukemia & Lymphoma
First Page
2539
Last Page
2542
Document Type
Article
Publication Date
10-2021
Department
Medicine
Recommended Citation
Jacoby, M. A., Finn, L., Emadi, A., Saba, N. S., Powell, B. L., Seiter, K., Garcia, R., Faderl, S., & Male, H. J. (2021). Frequency of Infusion-Related Reactions with CPX-351 Treatment in an Observational Study in Adults with Newly Diagnosed Therapy-Related AML or AML with Myelodysplasia-Related Changes (AML-MRC). Leukemia & Lymphoma, 62 (10), 2539-2542. https://doi.org/10.1080/10428194.2021.1919668
COinS